Long-term effects of ovulation-stimulating drugs on cancer risk.

[1]  W. Willett,et al.  A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer. , 2006, Archives of internal medicine.

[2]  J. Schenker,et al.  Infertility, Ovulation Induction Treatments and the Incidence of Breast Cancer—a Historical Prospective Cohort of Israeli Women , 2006, Breast Cancer Research and Treatment.

[3]  H. Yarali,et al.  Ovarian adenomyoma following gonadotrophin treatment for infertility. , 2006, Reproductive biomedicine online.

[4]  J. Lubin,et al.  Uterine cancer after use of clomiphene citrate to induce ovulation. , 2005, American journal of epidemiology.

[5]  F. Clavel-Chapelon,et al.  Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. , 2004, Human reproduction.

[6]  L. Brinton,et al.  Breast cancer risk associated with ovulation-stimulating drugs. , 2004, Human reproduction.

[7]  L. Brinton,et al.  Ovarian cancer risk associated with varying causes of infertility. , 2004, Fertility and sterility.

[8]  L. Brinton,et al.  Ovarian Cancer Risk After the Use of Ovulation-Stimulating Drugs , 2004 .

[9]  R. Coates,et al.  Fertility Problems and Breast Cancer Risk in Young Women: a Case-Control Study in the United States , 1998, Cancer Causes & Control.

[10]  L. Bernstein.  Epidemiology of Endocrine-Related Risk Factors for Breast Cancer , 2004, Journal of Mammary Gland Biology and Neoplasia.

[11]  G. Creatsas,et al.  Oral Contraceptives and Reproductive System Cancer , 2003, Annals of the New York Academy of Sciences.

[12]  Valerie Beral,et al.  Breast cancer and hormone-replacement therapy in the Million Women Study , 2003, The Lancet.

[13]  K. Malone,et al.  Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women’s Contraceptive and Reproductive Experiences Study , 2003 .

[14]  A. Venn,et al.  Infertility medications and the risk of breast cancer. , 2003, Fertility and sterility.

[15]  D. Polyzos,et al.  Effects of tamoxifen on the human female genital tract: review of the literature. , 2003, European journal of gynaecological oncology.

[16]  N. Agnantis,et al.  Clear cell ovarian carcinoma in a pregnant woman with a history of infertility, endometriosis and unsuccessful IVF treatment. , 2003, European journal of gynaecological oncology.

[17]  M. Papa,et al.  Breast Cancer in Women With Recent Exposure to Fertility Medications is Associated With Poor Prognostic Features , 2003, Annals of Surgical Oncology.

[18]  A. Chetrit,et al.  The possible association between in vitro fertilization treatments and cancer development , 2002, International Journal of Gynecologic Cancer.

[19]  V. Beral,et al.  Cancer incidence following treatment for infertility at a clinic in the UK. , 2002, Human reproduction.

[20]  P. Hartge,et al.  Menopausal hormone replacement therapy and risk of ovarian cancer. , 2002, JAMA.

[21]  M. Goodman,et al.  Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. , 2002, American journal of epidemiology.

[22]  B. Modan,et al.  Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. , 2002, Fertility and sterility.

[23]  L. Devoto,et al.  Clomiphene citrate and ovulation induction. , 2002, Reproductive biomedicine online.

[24]  A. Venn,et al.  Mortality in a cohort of IVF patients. , 2001, Human reproduction.

[25]  G. Adamson,et al.  The risk of ovarian cancer associated with infertility and infertility treatments. , 2001 .

[26]  J. Schenker,et al.  Ovulation induction and risk of endometrial cancer: a pilot study. , 2001, European journal of obstetrics, gynecology, and reproductive biology.

[27]  A. Zeleniuch‐Jacquotte,et al.  Role of Exogenous and Endogenous Hormones in Endometrial Cancer , 2001, Annals of the New York Academy of Sciences.

[28]  C. la Vecchia,et al.  Use of fertility drugs and risk of ovarian cancer. , 2001, Human reproduction.

[29]  L. Titus-Ernstoff.  An overview of the epidemiology of cutaneous melanoma. , 2000, Clinics in plastic surgery.

[30]  A. Venn,et al.  Risk of cancer after use of fertility drugs with in-vitro fertilisation , 1999, The Lancet.

[31]  C. la Vecchia,et al.  Fertility drugs and the risk of breast cancer. , 1999, Human reproduction.

[32]  A. Chetrit,et al.  Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. , 1999, Fertility and sterility.

[33]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[34]  E. H. Stephen,et al.  Updated projections of infertility in the United States: 1995-2025. , 1998, Fertility and sterility.

[35]  K. Tewari,et al.  Fertility drugs and malignant germ-cell tumour of ovary in pregnancy , 1998, The Lancet.

[36]  C. la Vecchia,et al.  Treatment for fertility and risk of ovarian tumors of borderline malignancy. , 1998, Gynecologic oncology.

[37]  B. Modan,et al.  Cancer incidence in a cohort of infertile women. , 1987, American journal of epidemiology.

[38]  C. la Vecchia,et al.  Treatment for infertility and risk of invasive epithelial ovarian cancer. , 1997, Human Reproduction.

[39]  I. Adewole,et al.  Ovarian cancer associated with ovulation induction: a case report. , 1997, African journal of medicine and medical sciences.

[40]  S. Kjaer,et al.  Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. , 1997, Fertility and sterility.

[41]  A. Leminen,et al.  Malignant tumors of the ovary or the breast in association with infertility: a report of thirteen cases , 1997, Acta obstetricia et gynecologica Scandinavica.

[42]  L. Mauriac,et al.  Breast cancer and in vitro fertilization. About 32 cases. , 1996, European journal of obstetrics, gynecology, and reproductive biology.

[43]  Julian Peto,et al.  Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies , 1996, The Lancet.

[44]  C. la Vecchia,et al.  Fertility treatment and risk of breast cancer. , 1996, Human reproduction.

[45]  J. Schenker,et al.  Human menopausal gonadotropin and the risk of epithelial ovarian cancer. , 1996, Fertility and sterility.

[46]  M. Maiman,et al.  Ovarian cancer after successful ovulation induction: a case report. , 1996, The Journal of reproductive medicine.

[47]  S. Self,et al.  Risk of breast cancer in a cohort of infertile women. , 1996, Gynecologic oncology.

[48]  A. Venn,et al.  Breast and ovarian cancer incidence after infertility and in vitro fertilisation , 1995, The Lancet.

[49]  S. Self,et al.  Ovarian tumors in a cohort of infertile women. , 1994, The New England journal of medicine.

[50]  C. la Vecchia,et al.  Fertility drugs and risk of epithelial ovarian cancer in Italy. , 1994, Human reproduction.

[51]  G. Glendon,et al.  In-vitro fertilisation and family history of breast cancer , 1994, The Lancet.

[52]  H. Adami,et al.  Transient increase in the risk of breast cancer after giving birth. , 1994, The New England journal of medicine.

[53]  S. Mor-Yosef,et al.  Ovarian stimulation and breast cancer: is there a link? , 1994, Gynecologic oncology.

[54]  M. Leroy-Billiard,et al.  [The possible endometrial risk of ovarian stimulation. Apropos of 3 cases]. , 1994, Journal de gynecologie, obstetrique et biologie de la reproduction.

[55]  J. Balasch,et al.  Metastatic ovarian strumosis in an in-vitro fertilization patient. , 1993, Human reproduction.

[56]  D. Wysowski.  Use of fertility drugs in the United States, 1973 through 1991. , 1993, Fertility and sterility.

[57]  P. Lopes,et al.  Ovarian cancer and assisted reproductive technology. , 1993, European journal of obstetrics, gynecology, and reproductive biology.

[58]  C. la Vecchia,et al.  Lifelong menstrual pattern and risk of breast cancer. , 1993, Oncology.

[59]  A. Hanselaar,et al.  Ovarian stimulation and granulosa-cell tumour , 1993, The Lancet.

[60]  C. Johannes,et al.  Re: "Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women". , 1993, American journal of epidemiology.

[61]  J Halpern,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. I. Methods. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[62]  A. Whittemore,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[63]  A. Whittemore,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[64]  C. Runowicz,et al.  Ovarian carcinoma of low malignant potential, infertility, and induction of ovulation--is there a link? , 1992, American journal of obstetrics and gynecology.

[65]  J. Baak,et al.  Borderline malignancy of the ovary and controlled hyperstimulation, a report of 2 cases. , 1992, European journal of cancer.

[66]  J. Dietl.  Ovulation and ovarian cancer , 1991, The Lancet.

[67]  S. Fishel,et al.  Follicular stimulation for high tech pregnancies: are we playing it safe? , 1989, BMJ.

[68]  M. Pike,et al.  The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. , 1988, European journal of cancer & clinical oncology.

[69]  M. Pike,et al.  Do regular ovulatory cycles increase breast cancer risk? , 1985, Cancer.

[70]  D. Cramer,et al.  Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. , 1983, Journal of the National Cancer Institute.

[71]  M F Fathalla,et al.  Incessant ovulation--a factor in ovarian neoplasia? , 1971, Lancet.